Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Remifentanil for Mechanically Ventilated Patients in Intensive Care: Multicenter, Random, Double-blind, Parallel, Positive Control Clinical Trials

NCT05641909 is registered in ClinicalTrials.gov with Southeast University, China as lead sponsor.

NCT NCT05641909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05641909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Remifentanil for Mechanically Ventilated Patients in Intensive Care: Multicenter, Random, Double-blind, Parallel, Positive Control Clinical Trials
Lead sponsor
Southeast University, China
Phase
Phase 3
Overall status
Unknown status
Start date
August 1, 2021
Completion date
December 31, 2022
Enrollment
138 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

analgesia